Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M48,020Revenue $M4,934Net Margin (%)13.5Z-Score7.0
Enterprise Value $M48,927EPS $3.5Operating Margin %35.1F-Score4
P/E(ttm))43.9Cash Flow Per Share $7.1Pre-tax Margin (%)34.3Higher ROA y-yY
Price/Book8.110-y EBITDA Growth Rate %0Quick Ratio0.9Cash flow > EarningsY
Price/Sales9.05-y EBITDA Growth Rate %16.8Current Ratio1.2Lower Leverage y-yN
Price/Cash Flow12.9y-y EBITDA Growth Rate %50.3ROA % (ttm)8.0Higher Current Ratio y-yN
Dividend Yield %0.2Insider Buy (3m)0ROE % (ttm)12.4Less Shares Outstanding y-yN
Payout Ratio %7.0Shares Outstanding M196ROI % (ttm)11.5Gross Margin Increase y-yN

Gurus Latest Trades with SHPG

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SHPGJohn Paulson 2014-06-30 Add0.84%$142.83 - $234.98
($172.9)
$ 244.3541%Add 33.07%3,366,539
SHPGJohn Paulson 2013-12-31 Reduce-0.24%$113.87 - $140.87
($131.38)
$ 244.3586%Reduce -11.03%2,529,854
SHPGJohn Paulson 2013-06-30 Add0.98%$86.59 - $99.85
($93.74)
$ 244.35161%Add 107.43%2,843,500
SHPGMario Gabelli 2013-03-31 Sold Out -0.003%$89.83 - $101.63
($95.88)
$ 244.35155%Sold Out0
SHPGJohn Paulson 2012-09-30 Buy 0.99%$84.65 - $95.05
($89.88)
$ 244.35172%New holding, 1370800 sh.1,370,800
SHPGJohn Hussman 2012-09-30 Sold Out -0.3%$84.65 - $95.05
($89.88)
$ 244.35172%Sold Out0
SHPGMario Gabelli 2012-03-31 Buy $97.29 - $108.2
($96.3)
$ 244.35154%New holding, 5460 sh.5,460
SHPGJohn Keeley 2012-03-31 Sold Out -0.0046%$97.29 - $108.2
($96.3)
$ 244.35154%Sold Out0
SHPGJohn Keeley 2011-12-31 Buy $88.04 - $103.9
($96.58)
$ 244.35153%New holding, 2105 sh.2,105
SHPGJohn Keeley 2011-09-30 Sold Out -0.0035%$87.43 - $104
($96.08)
$ 244.35154%Sold Out0
SHPGJohn Keeley 2011-06-30 Reduce$87.92 - $96.32
($91.76)
$ 244.35166%Reduce -36.62%2,285
SHPGJohn Keeley 2011-03-31 Buy $72.38 - $89.19
($81.84)
$ 244.35199%New holding, 3605 sh.3,605
SHPGGeorge Soros 2010-09-30 Sold Out -0.01%$62.31 - $71.18
($67.79)
$ 244.35260%Sold Out0
SHPGGeorge Soros 2010-06-30 Reduce$57.94 - $68.05
($63.93)
$ 244.35282%Reduce -49.52%5,300
SHPGGeorge Soros 2009-09-30 Buy 0.01%$40.25 - $53.24
($47.58)
$ 244.35414%New holding, 12000 sh.12,000
SHPGRon Baron 2009-06-30 Sold Out $36.04 - $42.91
($39.42)
$ 244.35520%Sold Out0
SHPGRon Baron 2009-03-31 Buy $33.61 - $46.56
($39.7)
$ 244.35516%New holding, 8200 sh.8,200
SHPGJean-Marie Eveillard 2009-03-31 Sold Out -0.09%$33.61 - $46.56
($39.7)
$ 244.35516%Sold Out0
SHPGJean-Marie Eveillard 2008-06-30 Reduce-0.03%$47.11 - $60.19
($52.2)
$ 244.35368%Reduce -32.57%181,274
SHPGDodge & Cox 2008-03-31 Sold Out $53.17 - $68.64
($59.4)
$ 244.35311%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SHPG is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SHPG John Paulson 2014-06-303,366,5391.713.4+33.07%
Premium Most recent portfolio changes are included for Premium Members only!


SHPG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about SHPG :

    Quarterly/Annual Reports about SHPG:

    News about SHPG:

    Articles On GuruFocus.com
    Invesco European Growth Fund Comments on Shire PLC Jul 29 2014 
    Invesco European Growth Fund Second Quarter 2014 Commentary Jul 29 2014 
    Weekly 52-Week Highs Highlight: SHPG, ILMN, UA, WDAY Feb 23 2014 
    Paulson Says Bet Against Europe to Blame for Down Year, Slashed EU Holdings in Q3 Dec 06 2012 
    John Paulson’s 4 Stocks Trading at 52-Week Lows Nov 28 2012 
    Top 4 International Stocks at 52-Week Low Prices Oct 31 2012 


    More From Other Websites
    [$$] Medtronic, AbbVie to Reimburse for Inversion-Triggered Taxes Aug 29 2014
    Protalix/Pfizer's Elelyso Approved in Pediatric Patients Aug 29 2014
    The Zacks Analyst Blog Highlights: RadioShack, Amicus Therapeutics, Sanofi, Shire and Gilead... Aug 28 2014
    3 Drugs Stocks Dragging The Industry Down Aug 27 2014
    [$$] Roche to Acquire InterMune for $8.3 Billion Aug 25 2014
    IRS, Eh? Tim Hortons Deal Could Lower Burger King's Tax Bill Aug 25 2014
    Burger King may buy Canada’s Tim Hortons to cut its taxes Aug 24 2014
    Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day Aug 22 2014
    Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results Aug 21 2014
    SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 21 2014
    Sanofi's (SNY) Cerdelga FDA Approved for Gaucher Disease Aug 20 2014
    Alcobra Starts Patient Enrollment for Mid-Stage Study on MDX Aug 20 2014
    Amicus Releases Positive Study Results On Rare Disease Drug Aug 20 2014
    Will The US Block Shire PLC’s Buyout And Prevent A Takeover Of AstraZeneca plc? Aug 19 2014
    [video] Latest motif: Tax inversion targets Aug 18 2014
    Supernus's SPN-810 Gets Fast Track Status for ADHD Aug 18 2014
    SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Aug 13 2014
    AbbVie-Shire Deal Still Offers Big Tax Savings Even Without an Inversion Aug 13 2014
    [video] Faber Report: New wave of tax inversions? Aug 13 2014
    Would Allergan back anti-offshoring law to ditch Valeant? Aug 11 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK